• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The significance of recurrent lung opacities in neonates on surfactant treatment for respiratory distress syndrome.

作者信息

Odita J C

机构信息

Department of Radiology, Louisiana State University Health Sciences Center, Shreveport 71130, USA.

出版信息

Pediatr Radiol. 2001 Feb;31(2):87-91. doi: 10.1007/s002470000377.

DOI:10.1007/s002470000377
PMID:11214692
Abstract

PURPOSE

To determine the significance of recurrent opacities in chest radiographs of neonates on surfactant therapy for respiratory distress syndrome (RDS) after an initial period of improvement.

MATERIALS AND METHODS

Serial pre-and post-surfactant chest radiographs on 94 preterm infants with RDS were analyzed and the pattern of chest radiographic response was classified as (a) clear, (b) recurrent opacities, and (c) no response. Their clinical characteristics were also recorded.

RESULTS

In 34 infants the RDS changes cleared within 3 days. 31 infants developed lung opacities within 10 days after an initial period of improvement. Twenty-nine infants failed to respond to the surfactant. The corresponding mean birth weights for the three groups were 1.74, 1.19, and 0.76 kg and the mean gestation ages 32.6, 27.7, and 25.4 weeks. The incidence of bronchopulmonary dysplasia (BPD) was highest among the slumping infants (72% vs. 50% in no responders, P<0.001)

CONCLUSIONS

The pattern of chest radiographic response is primarily affected by gestation age and birth weight. Recurrent lung opacity after an initial positive response to surfactant therapy may be caused by such factors as edema from barotrauma and patent ductus arteriosus. Infants with intraventricular hemorrhage may demonstrate neurogenic edema. Other contributory factors include pneumonia and abnormal consumption of surfactant. Recurrent lung opacities after surfactant may be a predictor of chronic lung disease in the preterm infant.

摘要

相似文献

1
The significance of recurrent lung opacities in neonates on surfactant treatment for respiratory distress syndrome.
Pediatr Radiol. 2001 Feb;31(2):87-91. doi: 10.1007/s002470000377.
2
Respiratory distress syndrome treated with human surfactant: radiographic findings.用人肺表面活性物质治疗的呼吸窘迫综合征:影像学表现
Radiology. 1985 Nov;157(2):329-34. doi: 10.1148/radiology.157.2.3840268.
3
Findings on chest radiographs after prophylactic pulmonary surfactant treatment of premature infants.
AJR Am J Roentgenol. 1989 Oct;153(4):799-802. doi: 10.2214/ajr.153.4.799.
4
Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.在患有呼吸窘迫综合征的早产儿中,使用单剂量重组牛肺表面活性剂进行通气后表面活性剂替代疗法:一项多中心、双盲、随机试验的最终分析及与类似试验的比较。表面活性剂-TA研究组
Pediatrics. 1990 Nov;86(5):753-64.
5
Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants.极低出生体重早产儿肺出血的短期转归。
Pediatr Neonatol. 2013 Oct;54(5):330-4. doi: 10.1016/j.pedneo.2013.04.005. Epub 2013 May 24.
6
[Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].足月儿和晚期早产儿呼吸窘迫综合征的临床特征及结局
Zhonghua Er Ke Za Zhi. 2008 Sep;46(9):654-7.
7
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.吸入或滴注类固醇用于预防支气管肺发育不良。
Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5.
8
Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome.
Pediatr Radiol. 1997 Jan;27(1):26-31. doi: 10.1007/s002470050057.
9
[The clinical comparative study of preterm respiratory distress syndrome and transient tachypnea of newborn].[早产新生儿呼吸窘迫综合征与新生儿短暂性呼吸急促的临床对比研究]
Zhonghua Er Ke Za Zhi. 2015 Feb;53(2):104-8.
10
A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.一项关于卢西纳可坦与猪肺磷脂在极早早产儿呼吸窘迫综合征高危人群中进行的多中心、随机、对照试验。
Pediatrics. 2005 Apr;115(4):1030-8. doi: 10.1542/peds.2004-2231.